KCI등재
SCOPUS
SCIE
Male Oxidative Stress Infertility (MOSI): Proposed Terminology and Clinical Practice Guidelines for Management of Idiopathic Male Infertility
저자
Ashok Agarwal (American Center for Reproductive Medicine, Cleveland Clinic) ; Neel Parekh (Department of Urology, Cleveland Clinic, Cleveland, OH, USA) ; Manesh Kumar Panner Selvam (American Center for Reproductive Medicine, Cleveland Clinic) ; Ralf Henkel (American Center for Reproductive Medicine, Cleveland Clinic) ; Rupin Shah (Department of Urology, Lilavati Hospital and Research Centre, Mumbai, India) ; Sheryl T. Homa (School of Biosciences, University of Kent, Canterbury, UK) ; Ranjith Ramasamy (Department of Urology, University of Miami, Miami, FL) ; Edmund Ko (Department of Urology, Loma Linda University Health, Loma Linda) ; Kelton Tremellen (Department of Obstetrics Gynaecology and Reproductive Medicine, Flinders University) ; Sandro Esteves (Division of Urology, Department of Surgery, University of Campinas (UNICAMP), Campinas) ; Ahmad Majzoub (American Center for Reproductive Medicine, Cleveland Clinic) ; Juan G. Alvarez (Centro Androgen, La Coruña, Spain and Harvard Medical School) ; David K. Gardner (School of BioSciences, University of Melbourne) ; Channa N. Jayasena (Section of Investigative Medicine, Imperial College London) ; Jonathan W. Ramsay (Department of Andrology, Hammersmith Hospital, London) ; Chak-Lam Cho (Department of Surgery, Union Hospital, Shatin, Hong Kong) ; Ramadan Saleh (Department of Dermatology, Venereology and Andrology, Faculty of Medicine, Sohag University) ; Denny Sakkas (Boston IVF, Waltham) ; James M. Hotaling (Department of Urology, University of Utah, Salt Lake City,) ; Scott D. Lundy (Department of Urology, Cleveland Clinic, Cleveland, OH, USA) ; Sarah Vij (Department of Urology, Cleveland Clinic, Cleveland, OH, USA) ; Joel Marmar (Cooper University Hospital, Camden, NJ, USA) ; Jaime Gosalvez (Departamento de Biología, Universidad Autónoma de Madrid, Madrid) ; Edmund Sabanegh (Department of Urology, Cleveland Clinic, Cleveland, OH, USA) ; Hyun Jun Park (Department of Urology, Pusan National University School of Medicine) ; Armand Zini (Department of Surgery, McGill University, Montreal, QC, Canada,) ; Parviz Kavoussi (Austin Fertility & Reproductive Medicine/Westlake IVF, Austin, TX, USA) ; Sava Micic (Uromedica Polyclinic, Kneza Milosa, Belgrade, Serbia) ; Ryan Smith (Department of Urology, University of Virginia, Charlottesville, VA, USA) ; Gian Maria Busetto (Sapienza University of Rome, Rome, Italy) ; Mustafa Emre Bakırcıoğlu (Istanbul Florence Nightingale Hospital, Istanbul, Turkey) ; Gerhard Haidl (Department of Dermatology, University Hospital Bonn, Bonn, Germany) ; Giancarlo Balercia (Polytechnic University of Marche, Umberto I Hospital, Ancona, Italy) ; Nicolás Garrido Puchalt (IVI Foundation Edificio Biopolo – Instituto de Investigación Sanitaria la Fe, Valencia, Spain,) ; Moncef Ben-Khalifa (University Hospital, School of Médicine and PERITOX Laboratory, Amiens, Frances) ; Nicholas Tadros (Division of Urology, Southern Illinois University School of Medicine, Springfield, IL, USA) ; Jackson Kirkman-Browne (The University of Birmingham Edgbaston) ; Sergey Moskovtsev (Department of Obstetrics and Gynaecology, University of Toronto, Toronto, ON, Canada) ; Xuefeng Huang (The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China) ; Edson Borges Jr (Fertility Medical Group, São Paulo, Brazil) ; Daniel Franken (Tygerberg Hospital, Tygerberg, South Africa) ; Natan Bar-Chama (Icahn School of Medicine at Mount Sinai, New York, NY, USA) ; Yoshiharu Morimoto (Horac Grand Front Osaka Clinic, Osaka) ; Kazuhisa Tomita (Horac Grand Front Osaka Clinic, Osaka) ; Vasan Satya Srini (Manipal Fertility, Bangalore, India) ; Willem Ombelet (Genk Institute for Fertility Technology, Genk) ; Elisabetta Baldi (Center of Excellence DeNothe, University of Florence) ; Monica Muratori (University of Florence, Florence, Italy) ; Yasushi Yumura (Yokohama City University Medical Center, Yokohama, Japan) ; Sandro La Vignera (University of Catania, Catania, Italy) ; Raghavender Kosgi (Androbest Andrology & Urology Center, Hyderabad, India) ; Marlon P. Martinez (University of Santo Tomas Hospital, Manila, Philippines) ; Donald P. Evenson (SCSA Diagnostics, Brookings, SD, USA) ; Daniel Suslik Zylbersztejn (Fleury Group and Hospital Israelita Albert Einstein, São Paulo) ; Matheus Roque (Origen, Center for Reproductive Medicine, Rio de Janeiro) ; Marcello Cocuzza (Department of Urology, University of São Paulo (USP)) ; Marcelo Vieira (Division of Urology, Infertility Center ALFA, São Paulo) ; Assaf Ben-Meir (Hebrew-University Hadassah Medical Center, Jerusalem) ; Raoul Orvieto (Chaim Sheba Medical Center (Tel Hashomer), Ramat Gan) ; Eliahu Levitas (Soroka University Medical Center, Ben-Gurion University of the Negev Beer-Sheva, Beersheba) ; Amir Wiser (IVF Unit, Meir Medical Center, Kfar Sava) ; Mohamed Arafa (Department of Urology, Hamad Medical Corporation, Doha, Qatar) ; Vineet Malhotra (Department of Andrology and Urology, Diyos Hospital) ; Sijo Joseph Parekattil (PUR Clinic, South Lake Hospital, Clermont) ; Haitham Elbardisi (Department of Urology, Hamad Medical Corporation, Doha, Qatar) ; Luiz Carvalho (Baby Center, Institute for Reproductive Medicine) ; Rima Dada (All India Institute of Medical Sciences, New Delhi, India) ; Christophe Sifer (Hôpitaux Universitaires Paris Seine Saint-Denis, Bondy, France) ; Pankaj Talwar (Department of Reproductive Medicine and Embryology, Manipal Hospital) ; Ahmet Gudeloglu (Department of Urology, Hacettepe University Faculty of Medicine, Ankara, Turkey) ; Ahmed M.A. Mahmoud (University Hospital Ghent, Ghent, Belgium) ; Khaled Terras (Hannibal International Clinic, Tunis) ; Chadi Yazbeck (Pierre Cherest and Hartman Clinics, Paris, France) ; Bojanic Nebojsa (Clinical Centre of Serbia, Faculty of Medicine, University of Belgrade, Belgrade, Serbia) ; Damayanthi Durairajanayagam (Sungai Buloh Campus, Jalan Hospital, Selangor, Malaysia) ; Ajina Mounir (University of Sousse, Sousse, Tunisia) ; Linda G. Kahn (New York University School of Medicine, New York) ; Saradha Baskaran (American Center for Reproductive Medicine, Cleveland Clinic) ; Rishma Dhillon Pai (Lilavati Hospital and Research Centre, Mumbai, India) ; Donatella Paoli (Sapienza University of Rome, Rome, Italy) ; Kristian Leisegang (University of the Western Cape, Cape Town) ; Mohamed-Reza Moein (Shahid Sadoughi Medical University, Yazd, Iran) ; Sonia Malik (Southend Fertility & IVF, Delhi, India) ; Onder Yaman (School of Medicine, University of Ankara, Ankara, Turkey) ; Luna Samanta (Ravenshaw University, Cutrack, India) ; Fouad Bayane (Marrakech Fertility Institute, Marrakech, Morocco) ; Sunil K. Jindal (Jindal Hospital, Meerut, India) ; Muammer Kendirci (Liv Hospital Ulus, Istanbul) ; Baris Altay (Ege University School of Medicine, İzmir, Turkey) ; Dragoljub Perovic (Center of Urology, CODRA Hospital, Podgorica, Montenegro) ; Avi Harlev (Ben Gurion University of the Negev, Beer Sheva, Israel)
발행기관
학술지명
The World Journal of Men's Health(The World Journal of Men's Health)
권호사항
발행연도
2019
작성언어
English
주제어
등재정보
KCI등재,SCOPUS,SCIE
자료형태
학술저널
발행기관 URL
수록면
296-312(17쪽)
KCI 피인용횟수
24
DOI식별코드
제공처
소장기관
Despite advances in the field of male reproductive health, idiopathic male infertility, in which a man has altered semen characteristics without an identifiable cause and there is no female factor infertility, remains a challenging condition to diagnose and manage. Increasing evidence suggests that oxidative stress (OS) plays an independent role in the etiology of male infertility, with 30% to 80% of infertile men having elevated seminal reactive oxygen species levels. OS can negatively affect fertility via a number of pathways, including interference with capacitation and possible damage to sperm membrane and DNA, which may impair the sperm’s potential to fertilize an egg and develop into a healthy embryo. Adequate evaluation of male reproductive potential should therefore include an assessment of sperm OS. We propose the term Male Oxidative Stress Infertility, or MOSI, as a novel descriptor for infertile men with abnormal semen characteristics and OS, including many patients who were previously classified as having idiopathic male infertility. Oxidation-reduction potential (ORP) can be a useful clinical biomarker for the classification of MOSI, as it takes into account the levels of both oxidants and reductants (antioxidants). Current treatment protocols for OS, including the use of antioxidants, are not evidence-based and have the potential for complications and increased healthcare-related expenditures. Utilizing an easy, reproducible, and cost-effective test to measure ORP may provide a more targeted, reliable approach for administering antioxidant therapy while minimizing the risk of antioxidant overdose. With the increasing awareness and understanding of MOSI as a distinct male infertility diagnosis, future research endeavors can facilitate the development of evidence-based treatments that target its underlying cause.
더보기분석정보
연월일 | 이력구분 | 이력상세 | 등재구분 |
---|---|---|---|
2023 | 평가예정 | 해외DB학술지평가 신청대상 (해외등재 학술지 평가) | |
2020-01-01 | 평가 | 등재학술지 유지 (해외등재 학술지 평가) | KCI등재 |
2017-09-01 | 평가 | SCIE 등재 (기타) | KCI등재 |
2016-01-01 | 평가 | 등재학술지 유지 (계속평가) | KCI등재 |
2012-11-23 | 학술지명변경 | 한글명 : 대한남성과학회지 -> The World Journal of Men's Health외국어명 : The Korean Journal of Andrology -> The World Journal of Men's Health | KCI등재 |
2012-01-01 | 평가 | 등재학술지 유지 (등재유지) | KCI등재 |
2009-01-01 | 평가 | 등재학술지 선정 (등재후보2차) | KCI등재 |
2008-01-01 | 평가 | 등재후보 1차 PASS (등재후보1차) | KCI후보 |
2007-01-01 | 평가 | 등재후보학술지 유지 (등재후보2차) | KCI후보 |
2006-01-01 | 평가 | 등재후보 1차 PASS (등재후보1차) | KCI후보 |
2004-01-01 | 평가 | 등재후보학술지 선정 (신규평가) | KCI후보 |
기준연도 | WOS-KCI 통합IF(2년) | KCIF(2년) | KCIF(3년) |
---|---|---|---|
2016 | 0.15 | 0.15 | 0.18 |
KCIF(4년) | KCIF(5년) | 중심성지수(3년) | 즉시성지수 |
0.17 | 0.14 | 0.457 | 0.04 |
서지정보 내보내기(Export)
닫기소장기관 정보
닫기권호소장정보
닫기오류접수
닫기오류 접수 확인
닫기음성서비스 신청
닫기음성서비스 신청 확인
닫기이용약관
닫기학술연구정보서비스 이용약관 (2017년 1월 1일 ~ 현재 적용)
학술연구정보서비스(이하 RISS)는 정보주체의 자유와 권리 보호를 위해 「개인정보 보호법」 및 관계 법령이 정한 바를 준수하여, 적법하게 개인정보를 처리하고 안전하게 관리하고 있습니다. 이에 「개인정보 보호법」 제30조에 따라 정보주체에게 개인정보 처리에 관한 절차 및 기준을 안내하고, 이와 관련한 고충을 신속하고 원활하게 처리할 수 있도록 하기 위하여 다음과 같이 개인정보 처리방침을 수립·공개합니다.
주요 개인정보 처리 표시(라벨링)
목 차
3년
또는 회원탈퇴시까지5년
(「전자상거래 등에서의 소비자보호에 관한3년
(「전자상거래 등에서의 소비자보호에 관한2년
이상(개인정보보호위원회 : 개인정보의 안전성 확보조치 기준)개인정보파일의 명칭 | 운영근거 / 처리목적 | 개인정보파일에 기록되는 개인정보의 항목 | 보유기간 | |
---|---|---|---|---|
학술연구정보서비스 이용자 가입정보 파일 | 한국교육학술정보원법 | 필수 | ID, 비밀번호, 성명, 생년월일, 신분(직업구분), 이메일, 소속분야, 웹진메일 수신동의 여부 | 3년 또는 탈퇴시 |
선택 | 소속기관명, 소속도서관명, 학과/부서명, 학번/직원번호, 휴대전화, 주소 |
구분 | 담당자 | 연락처 |
---|---|---|
KERIS 개인정보 보호책임자 | 정보보호본부 김태우 | - 이메일 : lsy@keris.or.kr - 전화번호 : 053-714-0439 - 팩스번호 : 053-714-0195 |
KERIS 개인정보 보호담당자 | 개인정보보호부 이상엽 | |
RISS 개인정보 보호책임자 | 대학학술본부 장금연 | - 이메일 : giltizen@keris.or.kr - 전화번호 : 053-714-0149 - 팩스번호 : 053-714-0194 |
RISS 개인정보 보호담당자 | 학술진흥부 길원진 |
자동로그아웃 안내
닫기인증오류 안내
닫기귀하께서는 휴면계정 전환 후 1년동안 회원정보 수집 및 이용에 대한
재동의를 하지 않으신 관계로 개인정보가 삭제되었습니다.
(참조 : RISS 이용약관 및 개인정보처리방침)
신규회원으로 가입하여 이용 부탁 드리며, 추가 문의는 고객센터로 연락 바랍니다.
- 기존 아이디 재사용 불가
휴면계정 안내
RISS는 [표준개인정보 보호지침]에 따라 2년을 주기로 개인정보 수집·이용에 관하여 (재)동의를 받고 있으며, (재)동의를 하지 않을 경우, 휴면계정으로 전환됩니다.
(※ 휴면계정은 원문이용 및 복사/대출 서비스를 이용할 수 없습니다.)
휴면계정으로 전환된 후 1년간 회원정보 수집·이용에 대한 재동의를 하지 않을 경우, RISS에서 자동탈퇴 및 개인정보가 삭제처리 됩니다.
고객센터 1599-3122
ARS번호+1번(회원가입 및 정보수정)